Cytolysin‐positive Enterococcus faecalis is not increased in patients with non‐alcoholic steatohepatitis. (23rd January 2020)

• Record Type: Journal Article
• Authors: Lang, Sonja; Demir, Münevver; Duan, Yi; Martin, Anna; Schnabl, Bernd
• Is Part Of: Liver international. Volume 40:Number 4(2020)
• Page Start: 860
• Page End: 865
• Publication Date: 2020-01-23
• Subjects: microbiome -- microbiota -- virulence factors; Liver -- Periodicals; Liver -- Diseases -- Periodicals; 616.362
• DOI: 10.1111/liv.14377
• Languages: English
• ISSNs: 1478-3223

Abstract

Abstract: Several studies show associations between gut bacterial dysbiosis and chronic liver diseases, but causative mechanisms are largely unclear. We recently identified cytolysin, a bacterial exotoxin expressed and secreted by Enterococcus faecalis to cause liver damage in the setting of alcohol‐related liver disease. Cytolysin was increased and highly correlated with liver disease severity and mortality in alcoholic hepatitis patients. In this study, we investigated if faecal cytolysin‐positivity can be linked to non‐alcoholic fatty liver disease, a highly prevalent disease where new biomarkers and treatment targets are urgently needed. In contrast to what we observed in alcoholic hepatitis, only seven out of 96 non‐alcoholic fatty liver disease patients were cytolysin‐positive, and these patients did not have increased liver disease activity compared with cytolysin‐negative patients. These results indicate that the association of cytolysin carriage with worse clinical outcome might be specific for alcoholic hepatitis.